97 DNA methylation testing for endometrial cancer detection in patient-friendly sample types REFERENCES 1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA: a cancer journal for clinicians. 2019;69(1):7-34. 2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians. 2021;71(3):209-49. 3. Felix AS, Brinton LA. Cancer Progress and Priorities: Uterine Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2018;27(9):985-94. 4. Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, et al. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2016;26(1):2-30. 5. Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. Lancet (London, England). 2016;387(10023):1094-108. 6. Cooper NA, Barton PM, Breijer M, Caffrey O, Opmeer BC, Timmermans A, et al. Cost-effectiveness of diagnostic strategies for the management of abnormal uterine bleeding (heavy menstrual bleeding and post-menopausal bleeding): a decision analysis. Health technology assessment (Winchester, England). 2014;18(24):1-201, v-vi. 7. De Iaco P, Marabini A, Stefanetti M, Del Vecchio C, Bovicelli L. Acceptability and pain of outpatient hysteroscopy. The Journal of the American Association of Gynecologic Laparoscopists. 2000;7(1):71-5. 8. Lipscomb GH, Lopatine SM, Stovall TG, Ling FW. A randomized comparison of the Pipelle, Accurette, and Explora endometrial sampling devices. American journal of obstetrics and gynecology. 1994;170(2):591-4. 9. Clarke MA, Long BJ, Del Mar Morillo A, Arbyn M, Bakkum-Gamez JN, Wentzensen N. Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis. JAMA internal medicine. 2018;178(9):1210-22. 10. Sundar S, Balega J, Crosbie E, Drake A, Edmondson R, Fotopoulou C, et al. BGCS uterine cancer guidelines: Recommendations for practice. European journal of obstetrics, gynecology, and reproductive biology. 2017;213:71-97. 11. Mehta SP, Patel TS, Jana T, Samanta ST, Malvania R, Trivedi PP, et al. How useful are cervical Pap smears in detecting endometrial carcinomas? A tertiary cancer center experience. Diagnostic cytopathology. 2021;49(1):127-31. 12. Wang Y, Li L, Douville C, Cohen JD, Yen TT, Kinde I, et al. Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers. Science translational medicine. 2018;10(433). 13. Maver PJ, Poljak M. Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2020;26(5):579-83. 4
RkJQdWJsaXNoZXIy MjY0ODMw